A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
暂无分享,去创建一个
[1] R. Spaide. Choroidal Neovascularization , 2020, Pathologic Myopia.
[2] Malcolm Kohler,et al. A prospective evaluation , 2016 .
[3] G. Ying,et al. Size and Growth of Geographic Atrophy During 5 Years of Follow Up in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) , 2016 .
[4] Christian Simader,et al. Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD. , 2016, Ophthalmology.
[5] I. Mantel,et al. Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration. , 2015, American journal of ophthalmology.
[6] S. Byeon,et al. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age‐related macular degeneration , 2015, Acta ophthalmologica.
[7] Glenn J Jaffe,et al. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials. , 2015, Ophthalmology.
[8] R. Spaide,et al. MULTIMODAL IMAGING FINDINGS AND MULTIMODAL VISION TESTING IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2015, Retina.
[9] P. Campochiaro,et al. Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab. , 2015, Ophthalmology.
[10] C. Curcio,et al. OUTER RETINAL TUBULATION IN ADVANCED AGE-RELATED MACULAR DEGENERATION: Optical Coherence Tomographic Findings Correspond to Histology , 2015, Retina.
[11] Georg Langs,et al. Spatio-Temporal Signatures to Predict Retinal Disease Recurrence , 2015, IPMI.
[12] Georg Langs,et al. Predicting Semantic Descriptions from Medical Images with Convolutional Neural Networks , 2015, IPMI.
[13] Z. Haskova,et al. Baseline predictors of early visual acuity improvement in RVO patients treated with ranibizumab in the SHORE study , 2015 .
[14] I. Mantel,et al. REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome , 2015, Retina.
[15] Christoph K. Hitzenberger,et al. Progression of Retinal Pigment Epithelial Atrophy in Antiangiogenic Therapy of Neovascular Age-Related Macular Degeneration , 2015, American journal of ophthalmology.
[16] I. Mantel,et al. INCIDENCE OF OUTER RETINAL TUBULATION IN RANIBIZUMAB-TREATED AGE-RELATED MACULAR DEGENERATION , 2015, Retina.
[17] G. Ying,et al. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials. , 2015, Ophthalmology.
[18] R. Fimmers,et al. Scotopic and Photopic Microperimetry in Patients With Reticular Drusen and Age-Related Macular Degeneration. , 2015, JAMA ophthalmology.
[19] C. Curcio,et al. Clinicopathological correlation of outer retinal tubulation in age-related macular degeneration. , 2015, JAMA ophthalmology.
[20] E. Stone. Genetic testing for age-related macular degeneration: not indicated now. , 2015, JAMA ophthalmology.
[21] Christian Simader,et al. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. , 2015, Ophthalmology.
[22] Sina Farsiu,et al. Relationship of central choroidal thickness with age-related macular degeneration status. , 2015, American journal of ophthalmology.
[23] Jesse J. Jung,et al. TYPE 3 NEOVASCULARIZATION: Evolution, Association With Pigment Epithelial Detachment, and Treatment Response as Revealed by Spectral Domain Optical Coherence Tomography , 2015, Retina.
[24] C. Curcio,et al. Inner Segment Remodeling and Mitochondrial Translocation in Cone Photoreceptors in Age-Related Macular Degeneration With Outer Retinal Tubulation. , 2015, Investigative ophthalmology & visual science.
[25] K. Freund,et al. En face OCT angiography demonstrates flow in early type 3 neovascularization (retinal angiomatous proliferation) , 2015, Eye.
[26] Milan Sonka,et al. Stratified Sampling Voxel Classification for Segmentation of Intraretinal and Subretinal Fluid in Longitudinal Clinical OCT Data , 2015, IEEE Transactions on Medical Imaging.
[27] Kang Zhang,et al. PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION , 2015, Retina.
[28] Edwin M. Stone,et al. Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy , 2015, Progress in Retinal and Eye Research.
[29] H. Kawashima,et al. Effects of posterior vitreous detachment on aqueous humour levels of VEGF and inflammatory cytokines , 2015, British Journal of Ophthalmology.
[30] Y. Modi,et al. Comparative Safety and Tolerability of Anti-VEGF Therapy in Age-Related Macular Degeneration , 2015, Drug Safety.
[31] Jiayan Huang,et al. Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). , 2015, Ophthalmology.
[32] H. Kim,et al. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. , 2015, American journal of ophthalmology.
[33] C. Ramsay,et al. Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review. , 2015, Ophthalmology.
[34] A. Schachat,et al. Optical coherence tomography, fluorescein angiography, and the management of neovascular age-related macular degeneration. , 2015, Ophthalmology.
[35] M. Tolentino,et al. Drugs in Phase II clinical trials for the treatment of age-related macular degeneration , 2015, Expert opinion on investigational drugs.
[36] Christian Simader,et al. Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments , 2015, British Journal of Ophthalmology.
[37] Jesse J. Jung,et al. GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[38] P. Campochiaro,et al. Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes. , 2015, American journal of ophthalmology.
[39] G. Ying,et al. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. , 2015, Ophthalmology.
[40] Terje R Pedersen,et al. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. , 2015, Ophthalmology.
[41] A. Ho,et al. Treatment outcomes after 3 years in neovascular age-related macular degeneration using a treat-and-extend regimen. , 2015, American journal of ophthalmology.
[42] G. Ying,et al. Outer retinal tubulation in the comparison of age-related macular degeneration treatments trials (CATT). , 2014, Ophthalmology.
[43] Lauren N Ayton,et al. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. , 2014, Ophthalmology.
[44] Richard F Spaide,et al. Visualization of the posterior vitreous with dynamic focusing and windowed averaging swept source optical coherence tomography. , 2014, American journal of ophthalmology.
[45] Eric M. Moult,et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. , 2014, Ophthalmic surgery, lasers & imaging retina.
[46] Robert Tibshirani,et al. Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. , 2014, Investigative ophthalmology & visual science.
[47] Ursula Schmidt-Erfurth,et al. A quantitative approach to identify morphological features relevant for visual function in ranibizumab therapy of neovascular AMD. , 2014, Investigative ophthalmology & visual science.
[48] K. Freund,et al. THE PEARL NECKLACE SIGN: A Novel Spectral Domain Optical Coherence Tomography Finding in Exudative Macular Disease , 2014, Retina.
[49] Jesse J. Jung,et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. , 2014, American journal of ophthalmology.
[50] Georg Langs,et al. Motion Artefact Correction in Retinal Optical Coherence Tomography Using Local Symmetry , 2014, MICCAI.
[51] Giovanni Staurenghi,et al. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration , 2014, British Journal of Ophthalmology.
[52] Georg Langs,et al. Stable registration of pathological 3D-OCT scans using retinal vessels , 2014 .
[53] Giovanni Staurenghi,et al. Clinical characteristics of reticular pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration. , 2014, Ophthalmology.
[54] Francesco Bandello,et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) , 2014, British Journal of Ophthalmology.
[55] Glenn J Jaffe,et al. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. , 2014, JAMA ophthalmology.
[56] U. Schmidt-Erfurth,et al. Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration. , 2014, American journal of ophthalmology.
[57] Myeong Jin Ju,et al. Simultaneous investigation of vascular and retinal pigment epithelial pathologies of exudative macular diseases by multifunctional optical coherence tomography. , 2014, Investigative ophthalmology & visual science.
[58] R. Guymer,et al. ANTI-VEGF TREATMENT IN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION: A Treat-and-Extend Protocol Over 2 Years , 2014, Retina.
[59] S. Sadda,et al. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus. , 2014, Ophthalmology.
[60] Christian Simader,et al. Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy , 2014, British Journal of Ophthalmology.
[61] Wolfgang Drexler,et al. Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes. , 2014, Investigative ophthalmology & visual science.
[62] S. Sadda,et al. Effect of Anti-VEGF Treatment on Choroidal Thickness over Time in Patients with Neovascular Age-related Macular Degeneration , 2014, European journal of ophthalmology.
[63] M. Larsen,et al. MULTILAYERED PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[64] A. Merkur,et al. EXACERBATION OF CHOROIDAL AND RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[65] K. Freund,et al. SUBRETINAL HYPERREFLECTIVE EXUDATION ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[66] E. Rahimy,et al. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis). , 2014, Transactions of the American Ophthalmological Society.
[67] Christian Simader,et al. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. , 2014, Ophthalmology.
[68] Jiayan Huang,et al. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). , 2014, JAMA ophthalmology.
[69] U Chakravarthy,et al. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity. , 2014, Ophthalmology.
[70] M. Sonka,et al. Quantifying disrupted outer retinal-subretinal layer in SD-OCT images in choroidal neovascularization. , 2014, Investigative ophthalmology & visual science.
[71] Jiayan Huang,et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. , 2014, Ophthalmology.
[72] Martin F. Kraus,et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. , 2014, Ophthalmology.
[73] Amitha Domalpally,et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. , 2014, Ophthalmology.
[74] Michael Pircher,et al. Adaptive optics SLO/OCT for 3D imaging of human photoreceptors in vivo. , 2014, Biomedical optics express.
[75] Chun-Fang Xu,et al. GENETIC FACTORS ASSOCIATED WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB IN KOREAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2014, Retina.
[76] Richard F Spaide,et al. Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft Drusen in vivo using adaptive optics imaging. , 2014, Ophthalmology.
[77] Alauddin Bhuiyan,et al. Progress on retinal image analysis for age related macular degeneration , 2014, Progress in Retinal and Eye Research.
[78] Hyuncheol Kim,et al. Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes. , 2014, Investigative Ophthalmology and Visual Science.
[79] Leopold Schmetterer,et al. Doppler Optical Coherence Tomography , 2014, Progress in Retinal and Eye Research.
[80] H. Flynn,et al. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. , 2013, Ophthalmic surgery, lasers & imaging retina.
[81] Glenn J Jaffe,et al. Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. , 2015, Ophthalmology.
[82] E. Stone,et al. Is age-related macular degeneration a microvascular disease? , 2014, Advances in experimental medicine and biology.
[83] R. Guymer,et al. Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration. , 2014, Survey of ophthalmology.
[84] Glenn J Jaffe,et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.
[85] Milan Sonka,et al. Relationships of retinal structure and humphrey 24-2 visual field thresholds in patients with glaucoma. , 2014, Investigative ophthalmology & visual science.
[86] Gerhard Goos,et al. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2014 , 2014, Lecture Notes in Computer Science.
[87] U. Schmidt-Erfurth,et al. Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration. , 2013, Ophthalmology.
[88] Susanne Binder,et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. , 2013, Ophthalmology.
[89] S. Harding,et al. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. , 2013, Ophthalmology.
[90] Pearse A Keane,et al. Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. , 2013, Ophthalmology.
[91] A. Roorda,et al. Cone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration. , 2013, Investigative ophthalmology & visual science.
[92] M. Larsen,et al. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. , 2013, American journal of ophthalmology.
[93] David R Williams,et al. In vivo imaging of retinal pigment epithelium cells in age related macular degeneration. , 2013, Biomedical optics express.
[94] Usha Chakravarthy,et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial , 2013, The Lancet.
[95] P. Keane,et al. Relationship between Visual Acuity and Spectral Domain Optical Coherence Tomography Retinal Parameters in Neovascular Age-Related Macular Degeneration , 2013, Ophthalmologica.
[96] S. Kishi,et al. Evolution of vitreomacular detachment in healthy subjects. , 2013, JAMA ophthalmology.
[97] Glenn J Jaffe,et al. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. , 2013, Ophthalmology.
[98] E. Rahimy,et al. PROSPECTIVE EVALUATION OF THE INCIDENCE AND RISK FACTORS FOR THE DEVELOPMENT OF RPE TEARS AFTER HIGH- AND LOW-DOSE RANIBIZUMAB THERAPY , 2013, Retina.
[99] Richard F Spaide,et al. Optical coherence tomography: imaging of the choroid and beyond. , 2013, Survey of ophthalmology.
[100] R. Guymer,et al. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. , 2013, Ophthalmology.
[101] M. Larsen,et al. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. , 2013, American journal of ophthalmology.
[102] W. Freeman,et al. CORRELATION OF SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS WITH VISUAL ACUITY IN EYES WITH SUBFOVEAL SCARRING AFTER TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION , 2013, Retina.
[103] M. Knopp,et al. ANATOMIC AND PHARMACOKINETIC PROPERTIES OF INTRAVITREAL BEVACIZUMAB AND RANIBIZUMAB AFTER VITRECTOMY AND LENSECTOMY , 2013, Retina.
[104] Allen C Ho,et al. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. , 2013, Ophthalmology.
[105] Sina Farsiu,et al. Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. , 2013, Ophthalmology.
[106] S. Sivaprasad,et al. Predictive value of spectral-domain optical coherence tomography features in assessment of visual prognosis in eyes with neovascular age-related macular degeneration treated with ranibizumab. , 2013, American journal of ophthalmology.
[107] Usha Chakravarthy,et al. Clinical classification of age-related macular degeneration. , 2013, Ophthalmology.
[108] F. Falcão-Reis,et al. Characterization of Neovascular Age-Related Macular Degeneration Patients with Outer Retinal Tubulations , 2013, Ophthalmologica.
[109] Gerard Mimoun,et al. CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE: The LUMIERE Study , 2013, Retina.
[110] William J Feuer,et al. QUANTITATIVE CHANGES IN RETINAL PIGMENT EPITHELIAL DETACHMENTS AS A PREDICTOR FOR RETREATMENT WITH ANTI-VEGF THERAPY , 2013, Retina.
[111] E. Souied,et al. MULTIMODAL EVALUATION OF FOVEAL SPARING IN PATIENTS WITH GEOGRAPHICATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION , 2013, Retina.
[112] P. Rosenfeld,et al. Increasing volume of a retinal pigmented epithelial detachment as a predictor of submacular hemorrhage during anti-VEGF therapy. , 2013, Ophthalmic surgery, lasers & imaging retina.
[113] Ivana K. Kim,et al. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). , 2013, Ophthalmology.
[114] H. Hoerauf,et al. Posterior vitreous detachment following intravitreal drug injection , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[115] R. Spaide,et al. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration. , 2013, Ophthalmology.
[116] M. Larsen,et al. Predictors of 1‐year visual outcome in neovascular age‐related macular degeneration following intravitreal ranibizumab treatment , 2013, Acta ophthalmologica.
[117] Correlation of OCT characteristics and retinal sensitivity in neovascular age-related macular degeneration in the course of monthly ranibizumab treatment. , 2013, Investigative ophthalmology & visual science.
[118] Glenn J Jaffe,et al. Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration. , 2013, Ophthalmology.
[119] E. Makalic,et al. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. , 2013, Ophthalmology.
[120] Jost B Jonas,et al. Subfoveal choroidal thickness: the Beijing Eye Study. , 2013, Ophthalmology.
[121] M. Mandai,et al. Recovery of photoreceptor outer segments after anti-VEGF therapy for age-related macular degeneration , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.
[122] Milan Sonka,et al. Quantification of external limiting membrane disruption caused by diabetic macular edema from SD-OCT. , 2012, Investigative ophthalmology & visual science.
[123] Judy E. Kim,et al. Ocular Hypertension Following Intravitreal Anti-vascular Endothelial Growth Factor Agents , 2012, Drugs & Aging.
[124] M. Sonka,et al. Automated segmentation of the choroid from clinical SD-OCT. , 2012, Investigative ophthalmology & visual science.
[125] B. J. Klevering,et al. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. , 2012, Ophthalmology.
[126] U. Schmidt-Erfurth,et al. Correlation of SD-OCT features and retinal sensitivity in neovascular age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.
[127] F. Roudot-thoraval,et al. Hyperreflective Dots: A New Spectral-Domain Optical Coherence Tomography Entity for Follow-Up and Prognosis in Exudative Age-Related Macular Degeneration , 2012, Ophthalmologica.
[128] Adnan Tufail,et al. Evaluation of age-related macular degeneration with optical coherence tomography. , 2012, Survey of ophthalmology.
[129] I. Bhutto,et al. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. , 2012, Molecular aspects of medicine.
[130] Hideki Koizumi,et al. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. , 2012, Ophthalmology.
[131] J. Kim,et al. Improvement of photoreceptor integrity and associated visual outcome in neovascular age-related macular degeneration. , 2012, American journal of ophthalmology.
[132] Stefanie G. Schuman,et al. Spatial correlation between hyperpigmentary changes on color fundus photography and hyperreflective foci on SDOCT in intermediate AMD. , 2012, Investigative ophthalmology & visual science.
[133] Noemi Lois,et al. Progression of retinal pigment epithelial atrophy in stargardt disease. , 2012, American journal of ophthalmology.
[134] Usha Chakravarthy,et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. , 2012, Ophthalmology.
[135] G. Ying,et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. , 2012, Ophthalmology.
[136] Harald Sattmann,et al. Polarization sensitive optical coherence tomography of melanin provides intrinsic contrast based on depolarization , 2012, Biomedical optics express.
[137] N. Bressler,et al. Impact of availability of anti-vascular endothelial growth factor therapy on visual impairment and blindness due to neovascular age-related macular degeneration. , 2012, Archives of ophthalmology.
[138] A. Tsujikawa,et al. Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization , 2012, Clinical ophthalmology.
[139] N. Hawkes. Avastin is as effective as Lucentis for wet AMD and could save NHS £84m a year, study shows , 2012, BMJ : British Medical Journal.
[140] U. Schmidt-Erfurth,et al. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. , 2012, Ophthalmology.
[141] P. Kaiser,et al. Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI study. , 2012, Ophthalmology.
[142] M. Neudorfer,et al. Differential optical density of subretinal spaces. , 2012, Investigative ophthalmology & visual science.
[143] R. Guymer,et al. Delay to treatment and visual outcomes in patients treated with anti-vascular endothelial growth factor for age-related macular degeneration. , 2012, American journal of ophthalmology.
[144] William J Feuer,et al. Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography. , 2012, American journal of ophthalmology.
[145] D. Jaafar,et al. Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration: a 12-month randomized prospective study. , 2012, American journal of ophthalmology.
[146] E. Souied,et al. LONGITUDINAL ANATOMICAL RESPONSE OF RETINAL–CHOROIDAL ANASTOMOSIS TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY , 2012, Retina.
[147] U. Schmidt-Erfurth,et al. INFLUENCE OF VITREOMACULAR ADHESION ON THE DEVELOPMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION: 4-Year Results of a Longitudinal Study , 2012, Retina.
[148] S. Boyd,et al. Effectiveness at 1 Year of Monthly versus Variable-Dosing Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration , 2012, Retina.
[149] P. Patel,et al. OPTIMIZING INDIVIDUALIZED THERAPY WITH BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. , 2012, Retina.
[150] A. Tsujikawa,et al. Relationship between retinal morphological findings and visual function in age-related macular degeneration , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.
[151] Bernhard Baumann,et al. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. , 2011, Ophthalmology.
[152] R. Molday,et al. Progress in Retinal and Eye Research , 2012 .
[153] L. Hjelmqvist,et al. One-Year Outcomes Using Ranibizumab for Neovascular Age-Related Macular Degeneration: Results of a Prospective and Retrospective Observational Multicentre Study , 2011, Journal of ophthalmology.
[154] E. Lenassi,et al. Efficacy of 12‐month treatment of neovascular age‐related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections , 2011, Acta ophthalmologica.
[155] U. Schmidt-Erfurth,et al. Polarization sensitive optical coherence tomography in the human eye , 2011, Progress in Retinal and Eye Research.
[156] C. Curcio,et al. ANATOMICAL CORRELATES TO THE BANDS SEEN IN THE OUTER RETINA BY OPTICAL COHERENCE TOMOGRAPHY: Literature Review and Model , 2011, Retina.
[157] Hyewon Chung,et al. ASSOCIATION BETWEEN FOVEAL MICROSTRUCTURE AND VISUAL OUTCOME IN AGE-RELATED MACULAR DEGENERATION , 2011, Retina.
[158] Srinivas R Sadda,et al. Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography. , 2011, Investigative ophthalmology & visual science.
[159] Joan W. Miller,et al. Spectral-domain optical coherence tomography as an indicator of fluorescein angiography leakage from choroidal neovascularization. , 2011, Investigative ophthalmology & visual science.
[160] E. Souied,et al. Cystoid macular degeneration in exudative age-related macular degeneration. , 2011, American journal of ophthalmology.
[161] C. Masuet-Aumatell,et al. ONE-YEAR RESULTS OF A FLEXIBLE REGIMEN WITH RANIBIZUMAB THERAPY IN MACULAR DEGENERATION: Relationship with the Number of Injections , 2011, Retina.
[162] Masahiro Akiba,et al. Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography. , 2011, Investigative ophthalmology & visual science.
[163] R. Guymer,et al. Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD. , 2011, Investigative ophthalmology & visual science.
[164] J. Townend,et al. GEOGRAPHIC ATROPHY IN RETINAL ANGIOMATOUS PROLIFERATION , 2011, Retina.
[165] Christian Ahlers,et al. Performance of automated drusen detection by polarization-sensitive optical coherence tomography. , 2011, Investigative ophthalmology & visual science.
[166] Glenn J Jaffe,et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. , 2011, The New England journal of medicine.
[167] Ivana K. Kim,et al. Genetics of Age-Related Macular Degeneration: Current Concepts, Future Directions , 2011, Seminars in ophthalmology.
[168] U. Schmidt-Erfurth,et al. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. , 2011, Ophthalmology.
[169] Joan W. Miller,et al. DISPLAYED REFLECTIVITY OF CHOROIDAL NEOVASCULAR MEMBRANES BY OPTICAL COHERENCE TOMOGRAPHY CORRELATES WITH PRESENCE of LEAKAGE BY FLUORESCEIN ANGIOGRAPHY , 2011, Retina.
[170] William J Feuer,et al. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. , 2011, Ophthalmology.
[171] R. Guymer,et al. Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study. , 2011, Ophthalmology.
[172] Shuichi Makita,et al. Three-dimensional visualization of ocular vascular pathology by optical coherence angiography in vivo. , 2011, Investigative ophthalmology & visual science.
[173] Dominic McHugh,et al. Optical coherence tomography may be used to predict visual acuity in patients with macular edema. , 2011, Investigative ophthalmology & visual science.
[174] H. Gerding,et al. Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[175] S. Mennel,et al. Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections , 2011, Acta ophthalmologica.
[176] D. Pauleikhoff,et al. [Anti-VEGF therapy of exudative AMD: Prognostic factors for therapy success]. , 2011, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[177] Susanne Binder,et al. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration , 2011, British Journal of Ophthalmology.
[178] Christian Simader,et al. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy. , 2011, Ophthalmology.
[179] R. Kawasaki,et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[180] H. Koh,et al. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration. , 2011, Ophthalmology.
[181] S. Sadda,et al. Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[182] P. Mitchell,et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.
[183] P. Charbel Issa,et al. The significance of the complement system for the pathogenesis of age-related macular degeneration — current evidence and translation into clinical application , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[184] K. Eng,et al. Effectiveness of intravitreal ranibizumab for the treatment of neovascular age-related macular degeneration in a Canadian retina practice: a retrospective review. , 2010, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[185] H. Koh,et al. Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration , 2010, Japanese Journal of Ophthalmology.
[186] P. Keane,et al. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[187] C. Regillo,et al. A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact. , 2010, Ophthalmology.
[188] S. Harding,et al. Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy , 2010, British Journal of Ophthalmology.
[189] K Bailey Freund,et al. Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.
[190] G. Quentel,et al. Retinal pseudocysts in age-related geographic atrophy. , 2010, American journal of ophthalmology.
[191] Masayuki Hata,et al. The significance of external limiting membrane status for visual acuity in age-related macular degeneration. , 2010, American journal of ophthalmology.
[192] D. Pauleikhoff,et al. Anti-VEGF-Therapie der exsudativen AMD , 2010, Der Ophthalmologe.
[193] Christian Ahlers,et al. Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. , 2010, Investigative ophthalmology & visual science.
[194] Don H. Anderson,et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in Retinal and Eye Research.
[195] U. Schmidt-Erfurth,et al. Effect of intravitreal bevacizumab (Avastin®) in neovascular age‐related macular degeneration using a treatment regimen based on optical coherence tomography: 6‐ and 12‐month results , 2009, Acta ophthalmologica.
[196] Laura A. Hecker,et al. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. , 2010, Human molecular genetics.
[197] K Bailey Freund,et al. Outer retinal tubulation: a novel optical coherence tomography finding. , 2009, Archives of ophthalmology.
[198] U. Schmidt-Erfurth,et al. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. , 2009, Ophthalmology.
[199] B. Rosner,et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.
[200] P. Keane,et al. Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation , 2009, British Journal of Ophthalmology.
[201] Takayuki Baba,et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[202] G. Quentel,et al. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting. , 2009, American journal of ophthalmology.
[203] U. Schmidt-Erfurth,et al. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration , 2009, British Journal of Ophthalmology.
[204] J. Xu,et al. What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence , 2009, Aging.
[205] Christian Ahlers,et al. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. , 2009, Investigative ophthalmology & visual science.
[206] Srinivas R Sadda,et al. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[207] A. Tsujikawa,et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.
[208] Joel S Schuman,et al. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. , 2009, Ophthalmology.
[209] Matthias Bolz,et al. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. , 2009, Ophthalmology.
[210] Xiaodong Wu,et al. Automated 3-D Intraretinal Layer Segmentation of Macular Spectral-Domain Optical Coherence Tomography Images , 2009, IEEE Transactions on Medical Imaging.
[211] Susanne Binder,et al. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. , 2009, Investigative ophthalmology & visual science.
[212] Ronald Klein,et al. Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. , 2009, Ophthalmology.
[213] Philip J Rosenfeld,et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. , 2009, American journal of ophthalmology.
[214] 이성준. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration : paired eye study , 2009 .
[215] P. Keane,et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.
[216] Paul G. Updike,et al. Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[217] D. Sarraf,et al. PREDICTORS OF Anti-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS , 2008, Retina.
[218] S. Mennel,et al. Vitreomacular traction and exudative age‐related macular degeneration , 2008, Acta ophthalmologica.
[219] Martin Oppermann,et al. Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.
[220] M. Trese,et al. Posterior Vitreous Detachment Alters Retinal Penetration of Intravitreal Bevacizumab (Avastin) in Rabbit Eyes , 2008 .
[221] Xiaodong Wu,et al. Intraretinal Layer Segmentation of Macular Optical Coherence Tomography Images Using Optimal 3-D Graph Search , 2008, IEEE Transactions on Medical Imaging.
[222] A. Bird,et al. FUNDUS AUTOFLUORESCENCE IMAGING: Review and Perspectives , 2008, Retina.
[223] U Chakravarthy,et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.
[224] C. Regillo,et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. , 2008, American journal of ophthalmology.
[225] V. Arshavsky,et al. Progress in Retinal and Eye Research , 2008 .
[226] P. Kaiser,et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. , 2007, American journal of ophthalmology.
[227] W. Brannath,et al. Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration? , 2007, American journal of ophthalmology.
[228] L. Jampol,et al. Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. , 2007, Survey of ophthalmology.
[229] D. Sarraf,et al. TEARS OF THE RETINAL PIGMENT EPITHELIUM: An Old Problem in a New Era , 2007, Retina.
[230] Jens Dreyhaupt,et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. , 2007, American journal of ophthalmology.
[231] R. Bhisitkul,et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.
[232] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[233] Edwin M Stone,et al. Macular degeneration. , 2007, Annual review of medicine.
[234] K. Eng,et al. Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.
[235] Philip J Rosenfeld,et al. Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[236] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[237] Richard F Spaide,et al. INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[238] L. Labree,et al. Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.
[239] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[240] Ronald Klein,et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.
[241] G. Staurenghi,et al. The Fellow Eye in Retinal Angiomatous Proliferation (RAP) , 2005 .
[242] Leslie Hyman,et al. A Simplified Severity Scale for Age-Related Macular Degeneration , 2005 .
[243] J. Sebag. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[244] Marco A Zarbin,et al. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[245] Neil M Bressler,et al. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.
[246] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[247] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[248] C. Curcio,et al. The Alabama Age-Related Macular Degeneration Grading System for donor eyes. , 1998, Investigative ophthalmology & visual science.
[249] G. Ripandelli,et al. Optical coherence tomography. , 1998, Seminars in ophthalmology.
[250] C K Dorey,et al. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. , 1995, Investigative ophthalmology & visual science.
[251] E Reichel,et al. Quantitative assessment of macular edema with optical coherence tomography. , 1995, Archives of ophthalmology.
[252] A. Fercher,et al. In vivo optical coherence tomography. , 1993, American journal of ophthalmology.
[253] Age-related macular degeneration. The Macular Photocoagulation Study. , 1984, American journal of ophthalmology.
[254] P. Henkind. Stereoscopic Atlas of Macular Diseases , 1971 .